Device
Nerivio REN device
Nerivio REN device is a medical device with 3 clinical trials. Currently 2 active trials ongoing.
Total Trials
3
Max Phase
—
Type
DEVICE
Molecule
—
Success Metrics
Active Trials
2(67%)
Phase Distribution
Ph not_applicable
1
33%
Ph phase_4
2
67%
Phase Distribution
0
Early Stage
0
Mid Stage
2
Late Stage
Phase Distribution3 total trials
Phase 4Post-market surveillance
2(66.7%)
N/ANon-phased studies
1(33.3%)
Highest Phase Reached
Phase 4Trial Status & Enrollment
Completion Rate
0.0%
0 of 0 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
2
trials recruiting
Total Trials
3
all time
Status Distribution
Active(3)
Detailed Status
Active, not recruiting2
Enrolling by invitation1
Development Timeline
Analytics
Development Status
Total Trials
3
Active
2
Success Rate
N/A
Most Advanced
Phase 4
Trials by Phase
Phase 42 (66.7%)
N/A1 (33.3%)
Trials by Status
active_not_recruiting267%
enrolling_by_invitation133%
Recent Activity
2 active trials
Showing 3 of 3
active_not_recruitingnot_applicable
Migraine Prevention With the Remote Electrical Neuromodulation (REN) Wearable: A Real-world Evidence Study
NCT07487701
enrolling_by_invitationphase_4
Treatment Patterns Among US Veterans Using Remote Electrical Neuromodulation (REN) for Migraine Treatment
NCT07336420
active_not_recruitingphase_4
Nerivio Efficacy Under High-Frequency Use
NCT07336056
Clinical Trials (3)
Showing 3 of 3 trials
NCT07487701Not Applicable
Migraine Prevention With the Remote Electrical Neuromodulation (REN) Wearable: A Real-world Evidence Study
NCT07336420Phase 4
Treatment Patterns Among US Veterans Using Remote Electrical Neuromodulation (REN) for Migraine Treatment
NCT07336056Phase 4
Nerivio Efficacy Under High-Frequency Use
All 3 trials loaded
Drug Details
- Intervention Type
- DEVICE
- Total Trials
- 3